Diabetic Emergencies
DR ADIB MURSYIDI IM
EMERGENCY AND TRAUMA DEPARTMENT, HCTM
Diabetic
Ketoacidosis
(DKA)
Introduction and Epidemiology
 Acute, life threatening complication of DM in predominant in Type 1
 Overall mortality is <1%, but a mortality rate >5% in the elderly has been reported
 Mortality in patients with DKA is frequently related to the underlying etiological
precipitant rather than the metabolic sequelae of hyperglycaemia or ketoacidosis
Precipitating Factors
 Common - infection (often pneumonia or urinary tract infection) &
discontinuation of or inadequate insulin therapy
 Acute major illnesses such as myocardial infarction, cerebrovascular accident,
sepsis, or pancreatitis.
 New-onset type 1 diabetes, in which DKA is a common presentation.
 Poor compliance with the insulin regimen.
Physiology
Insulin
 Ingested glucose is primary stimulant of
insulin release from B-cells of pancreas
 Insulin main action : Liver, adipose tissue
and skeletal muscle
 Deficiency in insulin secretion due to loss of islet cell mass in type 1 DM
 Initial stage  secretory failure of B cells impairs fuel storage
 Evident during glucose tolerance test
 Later stage  as level of insulin decrease, fuel stores are mobilized during fasting
 resulting hyperglycemia
 As disease progression  increase blood glucose level can no longer trigger
insulin activity  lead to cell starvation
Pathogenesis
 Complex relationship between insulin and
counterregulatory hormones
 DKA is a response to cellular starvation
due to insulin deficiency
 Relative absence insulin and excess
counterregulatory hormones result in
hyperglycemia
Insulin
Glucagon
Cortisol
Catecholamines
GH
Pathophysiology
Ketone Body Formation
 Lipolysis
 B-oxidation splits fatty acids into Acetyl-
CoA
 Acetyl-CoA either:
 Enter Kreb’s cycle to produce ATP
 Enters Ketogenic pathway to produce
acetoacetic acids (ketones body)
 Ketones bodies
 Acetoacetic acid (20%)  urine ketone strip
 B-hydroxybutyric acid (78%)  blood ketone strip
 Acetone (2%)  lungs
Clinical Presentation
 Diabetic ketoacidosis (DKA) usually evolves rapidly - over a 24-hour period.
 In contrast, symptoms of HHS develop more insidiously, often persisting for
several days before hospital admission.
 Clinical manifestation of DKA related directly to
 Hyperglycemia
 Volume depletion
 Acidosis
 Osmotic diuresis gradually led to volume loss, in addition to renal losses of Na, Cl,
K, Phos, Ca, Mg
Clinical Features
 Alteration of consciousness seems to correlate better with elevated serum
osmolality (>320mmol/kg) than with severity of metabolic acidosis
 Kussmaul respiration (increase rate and depth of breathing)
 Acetone produce fruity odor breathing
 Abdominal pain and tender in DKA correlate with level of acidosis
 Pain can be due to gastric dilatation, ileus or pancreatitis
Diagnosis
 Blood glucose >13.9 mmol/L
 Anion gap >10 mmol/L
 Bicarbonate <15 mmol/L
 pH <7.3
Differential Diagnosis
 Alcoholic ketoacidosis
 Starvation ketoacidosis
 Renal failure
 Lactic acidosis
 Ingestion
 Salicylates
 Ethylene glycol
 Methanol
Investigation
 FBC, renal profile, electrolyte (Ca, Mg, Phos)
 Blood glucose
 Urinalysis
 ECG
 VBG
 Calculate anion gap [Na – (Cl + HCO3)]
 Blood C&S as per indicated
Principles of Management
1. Volume repletion
2. Reversal of metabolic consequences of
insulin insufficiency
3. Correction of electrolyte and acid-base
balance
4. Recognition and treatment of
precipitating cause
5. Avoidance complications
Algorithm
Algorithm
Algorithm
DKA data flowsheet
Complications
Related to acute disease
 In general, the greater initial
 Serum osmolality
 BUN
 Blood glucose
 Serum HCO3 (<10 mEq/L)
 Infection and myocardial infarction main
contributors for mortality
Greater mortality
Complications - Related to therapy
Complication
Complications of DKA (summary)
Related to Acute Disease Related to Therapy Later Complication
Loss of airway Hypokalemia Recurrent anion gap
metabolic acidosis
Sepsis Hypophosphatemia Non-anion gap metabolic
acidosis
Myocardial infarction Acute respiratory distress
syndrome
Vascular thrombosis
Hypovolemic shock Cerebral edema Mucormycosis
Hypoglycemia
Disposition and follow up
 Required hospitalization in a monitored setting (ICU)
 Nursing experienced with IV Insulin infusion
What to monitor? Our treatment aim?
Parameters Rate Aim
DXT Hourly Drop by 3
VBG (HCO3, K) 1H
4H
6H
HCO3 rise by 3
K : 3-5 mmol/L
Ketone 4 hourly 0.5 mmol/L/H
BUSE 6 hourly
Vital signs, I/O charting Hourly Aim positive balance
Urine output >0.5ml/kg/H
Cardiac monitor
SPO2
Continuous
What else to monitor?
Clinical Monitor Possible causes
A
B
Respiration Tachypneic Worsening acidosis
C Circulation Hypotension
Arrythmias
Dehydration
Electrolyte
imbalance
D GCS Drop of GCS Hypoglycemia
Cerebral edema
Hyponatremia
Input/output aim?
 For I/O, how much of positive balance?
 Estimated deficit in DKA up to 100ml/kg (estimated 10% of body weight), in HHS up to
200ml/kg)
 Aim to replace this deficit within the next 24-48 hours
 Aim positive balance 2-3L within this period
If DXT < 14
 Once blood glucose falls below 14 mmol/L
 Switch to 5% dextrose at 125ml/H and reduce insulin infusion rate to 0.05
units/kg/hour; or
 Switch to 10% dextrose at 125ml/H with no change in insulin infusion rate
 If equipment is working but response to treatment inadequate, increase insulin
infusion rate by 1 unit/hr increments hourly until target achieved
When to stop/overlap IVI insulin?
 Resolution of DKA:
 Patient able to eat
 Blood ketone <0.3 mmol/L
 pH. >7.3
 Do not discontinue intravenous infusion until 30 minutes after S/C short acting
insulin has been given
 Calculating SC insulin:
 Estimated dose = patient’s weight (kg) x 0.5
 50% of dose as bedtime, another 50% to 3 basal bolus
 Example: 80 kg required approximately 80kg x 0.5 = 40 units in 24 hours
 Eg: short acting insulin 7u & 20 units bedtime
Hyperosmolar
Hyperglycemic
State (HHS)
Background
 HHS : characterized by progressive hyperglycemia and hyperosmolarity
 Mostly in poor controlled or undiagnosed Type 2 DM
 Occurred in elderly, with common risk factors being obesity
Pathophysiology
Insulin resistance
and/or deficiency
Osmotic diuresis
followed by impaired
renal excretion of
glucose
Inflammatory state with marked
elevation in proinflammatory
cytokines vs counter-regulatory
stress hormones (catecholamines,
GH, glucagon, cortisol)
As serum glucose
concentration
increases
Osmotic gradient
develops
Shifting water
from intracellular
into intravascular
compartment
Cellular
dehydration
Clinical features
 History and comorbidities
 Elderly, baseline cognitive impairment, multiple comorbid, referred for abnormalities in
V/S
 Mostly evolved over days to weeks
 Nonspecific complaints
 Malaise, weakness, anorexia, fatigue, vomiting, cognitive impairment
 15% may present with seizures (typically focal)
Diagnosis
Severe hyperglycemia (>33.3 mmol/L)
Elevated plasma osmolality (>315 mmol/kg)
Serum HCO3 >15 mmol/L
pH >7.3
Serum ketones negative to mild positive
* Important to recognize the potential for a variety of mixed acid-base patterns in patients with
HHS
Diagnostic Criteria
Treatment
Treatment
 Improvement of tissue perfusion is the key to effective recovery in HHS
 The therapeutic plan must be carefully considered and adjusted for concurrent
medical illnesses such as cardiac, renal, and pulmonary disease.
 Overzealous resuscitation can result in significant harms and should be avoided.
 Treating severely ill patients likely requiring intensive care unit
Correction of hypovolemia
Identifying and treating precipitating causes
Correcting electrolyte abnormalities
Gradual correction of hyperglycemia and hyperosmolarity
Frequent monitoring
 Begin normal saline infusion before insulin therapy is started.
 The average fluid deficit in HHS is in the range of 20% to 25% of total body water, or 8
to 12L.
 One half of the fluid deficits should be replaced over the initial 12 hours and the
balance over the next 24 hours when possible.
 Begin fluid resuscitation with 0.9% normal saline at a rate of 15 to 20 mL/kg/h during
the first hour, followed by rates from 4 to 14 mL/kg/h.
 Limit the rate of volume repletion during the first 4 hours to <50 mL/kg of normal
saline. Once hypotension, tachycardia, serum hyponatremia, and urinary output
improve, 0.45% NaCl can be used to replace the remaining free water deficit.
 Hourly glucose, electrolyte, and osmolality measurements should be taken to monitor
progress in the critically ill.
Any questions? NO PLEASE.
PROCEED.
“
”
Blood gas: VBG or ABG?
Blood gas: VBG or ABG?
 Kelly AM et al. Review Article – Can Venous Blood Gas Analysis Replace
Arterial in Emergency Medical Care. Emery Med Australas 2010; 22: 493 – 498
 For pH, 3 studies of patients with DKA (265 patients) were reviewed showing a
weighted mean difference of 0.02 pH units. Only one study, which was the largest
study (200 patients) reported 95% limits of agreement of pH that were -0.009 – 0.02 pH
units.
 For bicarbonate, 7 studies with just over 900 patients were reviewed showing a
weighted mean difference of -1.41 mmol/L. Only 2 studies (246 patients and 95
patients) reported 95% limits of agreement which ranged from -5.8 to +5.3 mmol/L.
Blood gas: VBG or ABG?
 Ma OJ et al. Arterial Blood Gas Results Rarely Influence Emergency Physician
Management of Patients with Suspected Diabetic Ketoacidosis. Acad Emerg Med
Aug 2003; 10(8): 836 – 41.
 ABG analysis changed ED physicians diagnosis in 1% (95% CI 0.3 – 3.6%) of patients
 ABG analysis changed ED physicians treatment in 3.5% (95% CI 0.3 – 3.6%) of patients
(Change from SQ to IV insulin or vice versa)
 ABG analysis changed patient disposition in 2.5% (95% CI 1.1% – 5.7%) of patients
 Venous pH correlated well with arterial pH with difference of -0.015 +/- 0.006 pH units
“
”
Insulin versus Electrolyte?
Insulin versus Electrolyte?
 Patients with DKA will have total body potassium depletion from osmotic diuresis
and electrolyte losses.
 Measured levels of serum potassium may be falsely normal or elevated due to
extracellular shifts of potassium from secondary acidosis.
 The American Diabetes Association (ADA) actually recommends obtaining a a
serum potassium level before initiating insulin, but this is based on anecdotal
evidence.
 That being said, according to Arora et al, approximately 5% of patients with DKA
will have hypokalemia.
Insulin versus Electrolyte?
 Eg: In VBG you will see your K+ is 2.8.
 If you start insulin therapy before electrolyte replacement, you will worsen
hypokalemia which is a very real cause of morbidity and mortality from cardiac
arrhythmias and respiratory muscle weakness.
 Why?
 Don’t forget that insulin will activate your Na-K ATPase which will shift potassium
intracellular and worsen your hypokalemia.
“
”
Do Sodium Bicarbonate really
benefit?
Do Sodium Bicarbonate really benefit?
 Chua et al. Bicarbonate in Diabetic Ketoacidosis – A Systematic Review. Ann
Intensive Care 2011; 1 (23). 44 studies of DKA patients reviewed which showed:
 Transient improvement in metabolic acidosis
 No improved glycemic control
 Risk of cerebral edema in pediatric patients
 No studies with pH <6.85
Do Sodium Bicarbonate really benefit?
 Duhon et al. Intravenous Sodium Bicarbonate Therapy in Severely Acidotic
Diabetic Ketoacidosis. Ann Pharmacother 2013. 47(7 – 8): 970 – 5.
 Retrospective study of 86 patients with DKA which showed:
 No difference in: Time to resolution of acidemia, time to hospital discharge, time on IV
insulin, potassium requirement in 1st 24hrs
 Subgroup Analysis of pH < 6.9 (n = 20) showed no statistical difference in time to
resolution of acidemia
“
”
Should We Bolus Insulin Before
Starting the Infusion?
Should We Bolus Insulin Before Starting
the Infusion?
 Is there any benefit to an initial insulin bolus in Diabetic Ketoacidosis?
 Goyal et al. Utility of Initial Bolus Insulin in the Treatment of Diabetic Ketoacidosis. J
Emerg Med 2010; 38(4): 422 – 7.
 Prospective, Observational Study of 157 patients with DKA:
 Insulin bolus at the start of an insulin infusion IS EQUIVALENT to no insulin bolus at the start
of an insulin infusion in several endpoints including:
 Decrease normalization of glucose
 Affect the rate of change of anion gap
 Reduce ED or hospital length of stay
 Insulin bolus at the start of an insulin infusion DOES:
 Increase hypoglycemic events by 6 fold (6% vs 1%) [NOT Statistically Significant]
References
 Tintinalli’s Emergency Medicine (Chapter 225, 227, 9th Edition)
 Up-to-date
 Medscape
Thank you

Diabetic Emergencies

  • 1.
    Diabetic Emergencies DR ADIBMURSYIDI IM EMERGENCY AND TRAUMA DEPARTMENT, HCTM
  • 2.
  • 3.
    Introduction and Epidemiology Acute, life threatening complication of DM in predominant in Type 1  Overall mortality is <1%, but a mortality rate >5% in the elderly has been reported  Mortality in patients with DKA is frequently related to the underlying etiological precipitant rather than the metabolic sequelae of hyperglycaemia or ketoacidosis
  • 4.
    Precipitating Factors  Common- infection (often pneumonia or urinary tract infection) & discontinuation of or inadequate insulin therapy  Acute major illnesses such as myocardial infarction, cerebrovascular accident, sepsis, or pancreatitis.  New-onset type 1 diabetes, in which DKA is a common presentation.  Poor compliance with the insulin regimen.
  • 5.
  • 6.
    Insulin  Ingested glucoseis primary stimulant of insulin release from B-cells of pancreas  Insulin main action : Liver, adipose tissue and skeletal muscle
  • 7.
     Deficiency ininsulin secretion due to loss of islet cell mass in type 1 DM  Initial stage  secretory failure of B cells impairs fuel storage  Evident during glucose tolerance test  Later stage  as level of insulin decrease, fuel stores are mobilized during fasting  resulting hyperglycemia  As disease progression  increase blood glucose level can no longer trigger insulin activity  lead to cell starvation
  • 8.
    Pathogenesis  Complex relationshipbetween insulin and counterregulatory hormones  DKA is a response to cellular starvation due to insulin deficiency  Relative absence insulin and excess counterregulatory hormones result in hyperglycemia Insulin Glucagon Cortisol Catecholamines GH
  • 9.
  • 10.
    Ketone Body Formation Lipolysis  B-oxidation splits fatty acids into Acetyl- CoA  Acetyl-CoA either:  Enter Kreb’s cycle to produce ATP  Enters Ketogenic pathway to produce acetoacetic acids (ketones body)
  • 11.
     Ketones bodies Acetoacetic acid (20%)  urine ketone strip  B-hydroxybutyric acid (78%)  blood ketone strip  Acetone (2%)  lungs
  • 12.
    Clinical Presentation  Diabeticketoacidosis (DKA) usually evolves rapidly - over a 24-hour period.  In contrast, symptoms of HHS develop more insidiously, often persisting for several days before hospital admission.  Clinical manifestation of DKA related directly to  Hyperglycemia  Volume depletion  Acidosis  Osmotic diuresis gradually led to volume loss, in addition to renal losses of Na, Cl, K, Phos, Ca, Mg
  • 13.
    Clinical Features  Alterationof consciousness seems to correlate better with elevated serum osmolality (>320mmol/kg) than with severity of metabolic acidosis  Kussmaul respiration (increase rate and depth of breathing)  Acetone produce fruity odor breathing  Abdominal pain and tender in DKA correlate with level of acidosis  Pain can be due to gastric dilatation, ileus or pancreatitis
  • 14.
    Diagnosis  Blood glucose>13.9 mmol/L  Anion gap >10 mmol/L  Bicarbonate <15 mmol/L  pH <7.3
  • 15.
    Differential Diagnosis  Alcoholicketoacidosis  Starvation ketoacidosis  Renal failure  Lactic acidosis  Ingestion  Salicylates  Ethylene glycol  Methanol
  • 16.
    Investigation  FBC, renalprofile, electrolyte (Ca, Mg, Phos)  Blood glucose  Urinalysis  ECG  VBG  Calculate anion gap [Na – (Cl + HCO3)]  Blood C&S as per indicated
  • 17.
    Principles of Management 1.Volume repletion 2. Reversal of metabolic consequences of insulin insufficiency 3. Correction of electrolyte and acid-base balance 4. Recognition and treatment of precipitating cause 5. Avoidance complications
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
    Complications Related to acutedisease  In general, the greater initial  Serum osmolality  BUN  Blood glucose  Serum HCO3 (<10 mEq/L)  Infection and myocardial infarction main contributors for mortality Greater mortality
  • 23.
  • 24.
  • 25.
    Complications of DKA(summary) Related to Acute Disease Related to Therapy Later Complication Loss of airway Hypokalemia Recurrent anion gap metabolic acidosis Sepsis Hypophosphatemia Non-anion gap metabolic acidosis Myocardial infarction Acute respiratory distress syndrome Vascular thrombosis Hypovolemic shock Cerebral edema Mucormycosis Hypoglycemia
  • 26.
    Disposition and followup  Required hospitalization in a monitored setting (ICU)  Nursing experienced with IV Insulin infusion
  • 27.
    What to monitor?Our treatment aim? Parameters Rate Aim DXT Hourly Drop by 3 VBG (HCO3, K) 1H 4H 6H HCO3 rise by 3 K : 3-5 mmol/L Ketone 4 hourly 0.5 mmol/L/H BUSE 6 hourly Vital signs, I/O charting Hourly Aim positive balance Urine output >0.5ml/kg/H Cardiac monitor SPO2 Continuous
  • 28.
    What else tomonitor? Clinical Monitor Possible causes A B Respiration Tachypneic Worsening acidosis C Circulation Hypotension Arrythmias Dehydration Electrolyte imbalance D GCS Drop of GCS Hypoglycemia Cerebral edema Hyponatremia
  • 29.
    Input/output aim?  ForI/O, how much of positive balance?  Estimated deficit in DKA up to 100ml/kg (estimated 10% of body weight), in HHS up to 200ml/kg)  Aim to replace this deficit within the next 24-48 hours  Aim positive balance 2-3L within this period
  • 30.
    If DXT <14  Once blood glucose falls below 14 mmol/L  Switch to 5% dextrose at 125ml/H and reduce insulin infusion rate to 0.05 units/kg/hour; or  Switch to 10% dextrose at 125ml/H with no change in insulin infusion rate  If equipment is working but response to treatment inadequate, increase insulin infusion rate by 1 unit/hr increments hourly until target achieved
  • 31.
    When to stop/overlapIVI insulin?  Resolution of DKA:  Patient able to eat  Blood ketone <0.3 mmol/L  pH. >7.3  Do not discontinue intravenous infusion until 30 minutes after S/C short acting insulin has been given
  • 32.
     Calculating SCinsulin:  Estimated dose = patient’s weight (kg) x 0.5  50% of dose as bedtime, another 50% to 3 basal bolus  Example: 80 kg required approximately 80kg x 0.5 = 40 units in 24 hours  Eg: short acting insulin 7u & 20 units bedtime
  • 33.
  • 34.
    Background  HHS :characterized by progressive hyperglycemia and hyperosmolarity  Mostly in poor controlled or undiagnosed Type 2 DM  Occurred in elderly, with common risk factors being obesity
  • 35.
    Pathophysiology Insulin resistance and/or deficiency Osmoticdiuresis followed by impaired renal excretion of glucose Inflammatory state with marked elevation in proinflammatory cytokines vs counter-regulatory stress hormones (catecholamines, GH, glucagon, cortisol)
  • 36.
    As serum glucose concentration increases Osmoticgradient develops Shifting water from intracellular into intravascular compartment Cellular dehydration
  • 38.
    Clinical features  Historyand comorbidities  Elderly, baseline cognitive impairment, multiple comorbid, referred for abnormalities in V/S  Mostly evolved over days to weeks  Nonspecific complaints  Malaise, weakness, anorexia, fatigue, vomiting, cognitive impairment  15% may present with seizures (typically focal)
  • 39.
    Diagnosis Severe hyperglycemia (>33.3mmol/L) Elevated plasma osmolality (>315 mmol/kg) Serum HCO3 >15 mmol/L pH >7.3 Serum ketones negative to mild positive * Important to recognize the potential for a variety of mixed acid-base patterns in patients with HHS
  • 40.
  • 41.
  • 42.
    Treatment  Improvement oftissue perfusion is the key to effective recovery in HHS  The therapeutic plan must be carefully considered and adjusted for concurrent medical illnesses such as cardiac, renal, and pulmonary disease.  Overzealous resuscitation can result in significant harms and should be avoided.  Treating severely ill patients likely requiring intensive care unit
  • 43.
    Correction of hypovolemia Identifyingand treating precipitating causes Correcting electrolyte abnormalities Gradual correction of hyperglycemia and hyperosmolarity Frequent monitoring
  • 44.
     Begin normalsaline infusion before insulin therapy is started.  The average fluid deficit in HHS is in the range of 20% to 25% of total body water, or 8 to 12L.  One half of the fluid deficits should be replaced over the initial 12 hours and the balance over the next 24 hours when possible.  Begin fluid resuscitation with 0.9% normal saline at a rate of 15 to 20 mL/kg/h during the first hour, followed by rates from 4 to 14 mL/kg/h.  Limit the rate of volume repletion during the first 4 hours to <50 mL/kg of normal saline. Once hypotension, tachycardia, serum hyponatremia, and urinary output improve, 0.45% NaCl can be used to replace the remaining free water deficit.  Hourly glucose, electrolyte, and osmolality measurements should be taken to monitor progress in the critically ill.
  • 45.
    Any questions? NOPLEASE. PROCEED.
  • 46.
  • 47.
    Blood gas: VBGor ABG?  Kelly AM et al. Review Article – Can Venous Blood Gas Analysis Replace Arterial in Emergency Medical Care. Emery Med Australas 2010; 22: 493 – 498  For pH, 3 studies of patients with DKA (265 patients) were reviewed showing a weighted mean difference of 0.02 pH units. Only one study, which was the largest study (200 patients) reported 95% limits of agreement of pH that were -0.009 – 0.02 pH units.  For bicarbonate, 7 studies with just over 900 patients were reviewed showing a weighted mean difference of -1.41 mmol/L. Only 2 studies (246 patients and 95 patients) reported 95% limits of agreement which ranged from -5.8 to +5.3 mmol/L.
  • 48.
    Blood gas: VBGor ABG?  Ma OJ et al. Arterial Blood Gas Results Rarely Influence Emergency Physician Management of Patients with Suspected Diabetic Ketoacidosis. Acad Emerg Med Aug 2003; 10(8): 836 – 41.  ABG analysis changed ED physicians diagnosis in 1% (95% CI 0.3 – 3.6%) of patients  ABG analysis changed ED physicians treatment in 3.5% (95% CI 0.3 – 3.6%) of patients (Change from SQ to IV insulin or vice versa)  ABG analysis changed patient disposition in 2.5% (95% CI 1.1% – 5.7%) of patients  Venous pH correlated well with arterial pH with difference of -0.015 +/- 0.006 pH units
  • 49.
  • 50.
    Insulin versus Electrolyte? Patients with DKA will have total body potassium depletion from osmotic diuresis and electrolyte losses.  Measured levels of serum potassium may be falsely normal or elevated due to extracellular shifts of potassium from secondary acidosis.  The American Diabetes Association (ADA) actually recommends obtaining a a serum potassium level before initiating insulin, but this is based on anecdotal evidence.  That being said, according to Arora et al, approximately 5% of patients with DKA will have hypokalemia.
  • 51.
    Insulin versus Electrolyte? Eg: In VBG you will see your K+ is 2.8.  If you start insulin therapy before electrolyte replacement, you will worsen hypokalemia which is a very real cause of morbidity and mortality from cardiac arrhythmias and respiratory muscle weakness.  Why?  Don’t forget that insulin will activate your Na-K ATPase which will shift potassium intracellular and worsen your hypokalemia.
  • 52.
  • 53.
    Do Sodium Bicarbonatereally benefit?  Chua et al. Bicarbonate in Diabetic Ketoacidosis – A Systematic Review. Ann Intensive Care 2011; 1 (23). 44 studies of DKA patients reviewed which showed:  Transient improvement in metabolic acidosis  No improved glycemic control  Risk of cerebral edema in pediatric patients  No studies with pH <6.85
  • 54.
    Do Sodium Bicarbonatereally benefit?  Duhon et al. Intravenous Sodium Bicarbonate Therapy in Severely Acidotic Diabetic Ketoacidosis. Ann Pharmacother 2013. 47(7 – 8): 970 – 5.  Retrospective study of 86 patients with DKA which showed:  No difference in: Time to resolution of acidemia, time to hospital discharge, time on IV insulin, potassium requirement in 1st 24hrs  Subgroup Analysis of pH < 6.9 (n = 20) showed no statistical difference in time to resolution of acidemia
  • 55.
    “ ” Should We BolusInsulin Before Starting the Infusion?
  • 56.
    Should We BolusInsulin Before Starting the Infusion?  Is there any benefit to an initial insulin bolus in Diabetic Ketoacidosis?  Goyal et al. Utility of Initial Bolus Insulin in the Treatment of Diabetic Ketoacidosis. J Emerg Med 2010; 38(4): 422 – 7.  Prospective, Observational Study of 157 patients with DKA:  Insulin bolus at the start of an insulin infusion IS EQUIVALENT to no insulin bolus at the start of an insulin infusion in several endpoints including:  Decrease normalization of glucose  Affect the rate of change of anion gap  Reduce ED or hospital length of stay  Insulin bolus at the start of an insulin infusion DOES:  Increase hypoglycemic events by 6 fold (6% vs 1%) [NOT Statistically Significant]
  • 57.
    References  Tintinalli’s EmergencyMedicine (Chapter 225, 227, 9th Edition)  Up-to-date  Medscape
  • 58.

Editor's Notes

  • #32 To avoid potential relapse
  • #36 (CRP, interleukins, TNF) increase hepatic gluconeogenesis and glycogenolysis
  • #45 The actual rate of fluid administration should be individualized for each patient, based on the level of renal and cardiac impairment.
  • #49 Other Reasons ABGs may not be preferred Although rare, ABGs can cause radial artery spasm, infarct, and/or aneurysms ABGs are painful to patients, even more so than IV access By the way, when is the last time you checked a Modified Allen’s Test before doing a radial ABG? Block off Radial and Ulnar Artery for 30 seconds Have pt make fist Let go of ulnar artery and should have color return in <10seconds If no color return or delayed…then pt DOES NOT have collateral blood flow (i.e. – Allen’s Test) Myth#1 Busted: VBG can be used in place of ABGs